1. Regulation of Tight Junctions for Therapeutic Advantages
   Lorenza González-Mariscal et al, 2013, Tight Junctions in Cancer Metastasis CrossRef
2. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer
   Linqi Yang et al, 2022, Frontiers in Genetics CrossRef
3. RETRACTED ARTICLE: Long non-coding RNA VPS9D1-AS1 promotes growth of colon adenocarcinoma by sponging miR-1301-3p and CLDN1
   Wei Liu, 2021, Human Cell CrossRef
4. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer
   Robson Francisco Carvalho et al, 2021, Cancers CrossRef
5. Еxpression of claudin-1, 3, and 4 in colorectal cancer and polyps
   N. А. Nefedova et al, 2016, Arkhiv patologii CrossRef
6. OMICfpp: a fuzzy approach for paired RNA-Seq counts
   Alberto Berral-Gonzalez et al, 2019, BMC Genomics CrossRef
7. Mouse Models of Human Claudin-Associated Disorders: Benefits and Limitations
   Murat Seker et al, 2019, International Journal of Molecular Sciences CrossRef
8. A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
   Qingzhou Guan et al, 2021, Frontiers in Genetics CrossRef
9. Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis
   Didi Zuo et al, 2020, Gastroenterology Research and Practice CrossRef
10. Identification of key claudin genes associated with survival prognosis and diagnosis in colon cancer through integrated bioinformatic analysis
    Rana A. Alghamdi et al, 2023, Frontiers in Genetics CrossRef
11. Tight Junctions in the Inflamed Gut
    Maria del Rocio Encarnacion-Garcia et al, 2022, Tight Junctions CrossRef